TSG-6 has also been identified as a key mediator of anti-inflammatory effects of human mesenchymal stem cells in models of myocardial infarction (4), corneal damage (16), peritonitis (17), traumatic brain injury (18), acute lung injury (19), wound healing (20), and type 1 diabetes (21). This evidence concerns the gene TNFAIP6 and injury.